Biopharma venture capital activity maintained its red-hot pace during the third quarter of 2018, driven by a handful of deals exceeding $200 million, according to a report released this week.
{iframe}https://www.genengnews.com/gen-news-highlights/vc-investment-jumps-51-year-over-year-during-q3/81256318/?utm_medium=newsletter&utm_source=gen+daily+news+highlights&utm_content=01&utm_campaign=gen+daily+news+highlights_20181010&oly_enc_id=1673d8247356b7u&ajs_trait_oebid=9675b9130356b7s{/iframe}